These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7645952

  • 21. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.
    Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S.
    Oncol Res; 1994; 6(7):311-20. PubMed ID: 7865906
    [Abstract] [Full Text] [Related]

  • 22. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A, Seth K, Kalra N, Shukla Y.
    Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Feb 01; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 26. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
    Chen F, Wang T, Wang J, Wang ZQ, Qian M.
    Acta Pharmacol Sin; 2008 Apr 01; 29(4):458-64. PubMed ID: 18358092
    [Abstract] [Full Text] [Related]

  • 27. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.
    Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S, Fojo T.
    J Clin Invest; 1995 May 01; 95(5):2205-14. PubMed ID: 7738186
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells.
    Yeh GC, Lopaczynska J, Poore CM, Phang JM.
    Cancer Res; 1992 Dec 01; 52(23):6692-5. PubMed ID: 1358437
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative resistance of idarubicin, doxorubicin and their C-13 alcohol metabolites in human MDR1 transfected NIH-3T3 cells.
    Kuffel MJ, Ames MM.
    Cancer Chemother Pharmacol; 1995 Dec 01; 36(3):223-6. PubMed ID: 7781142
    [Abstract] [Full Text] [Related]

  • 35. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Liu Z, Lheureux F, Pouliot JF, Heckel A, Bamberger U, Georges E.
    Mol Pharmacol; 1996 Sep 01; 50(3):482-92. PubMed ID: 8794885
    [Abstract] [Full Text] [Related]

  • 36. MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine.
    Russo D, Michelutti A, Melli C, Damiani D, Michieli MG, Candoni A, Zhou DC, Marie JP, Zittoun R, Baccarani M.
    Leukemia; 1995 Mar 01; 9(3):513-6. PubMed ID: 7885049
    [Abstract] [Full Text] [Related]

  • 37. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
    Pannocchia A, Revelli S, Tamponi G, Giorgianni A, Todde R, Bosia A, Ghigo D.
    Cell Biochem Funct; 1996 Mar 01; 14(1):11-8. PubMed ID: 8907249
    [Abstract] [Full Text] [Related]

  • 38. Effects of R-enantiomer (GR66234A) and L-enantiomer (GR66235A) of telupidine, a new dihydropyridine derivative, on cell lines displaying the multidrug resistant phenotype.
    Tolomeo M, Gancitano RA, Musso M, Porretto F, Perricone R, Abbadessa V, Cajozzo A.
    Haematologica; 1994 Mar 01; 79(4):328-33. PubMed ID: 7806087
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.